19-35034040-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_199037.5(SCN1B):​c.749G>C​(p.Arg250Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,549,996 control chromosomes in the GnomAD database, including 16,715 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250K) has been classified as Benign.

Frequency

Genomes: 𝑓 0.13 ( 1462 hom., cov: 32)
Exomes 𝑓: 0.14 ( 15253 hom. )

Consequence

SCN1B
NM_199037.5 missense

Scores

1
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.409
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036869943).
BP6
Variant 19-35034040-G-C is Benign according to our data. Variant chr19-35034040-G-C is described in ClinVar as [Benign]. Clinvar id is 36756.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-35034040-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN1BNM_001037.5 linkc.448+301G>C intron_variant Intron 3 of 5 ENST00000262631.11 NP_001028.1 Q07699-1
SCN1BNM_199037.5 linkc.749G>C p.Arg250Thr missense_variant Exon 3 of 3 NP_950238.1 Q07699-2
SCN1BNM_001321605.2 linkc.349+301G>C intron_variant Intron 3 of 5 NP_001308534.1 Q07699A0A1W2PR05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN1BENST00000262631.11 linkc.448+301G>C intron_variant Intron 3 of 5 1 NM_001037.5 ENSP00000262631.3 Q07699-1

Frequencies

GnomAD3 genomes
AF:
0.132
AC:
20133
AN:
151974
Hom.:
1465
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0634
Gnomad AMI
AF:
0.117
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.259
Gnomad EAS
AF:
0.198
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.189
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.155
Gnomad OTH
AF:
0.166
GnomAD3 exomes
AF:
0.144
AC:
22249
AN:
154732
Hom.:
1785
AF XY:
0.144
AC XY:
11794
AN XY:
81752
show subpopulations
Gnomad AFR exome
AF:
0.0617
Gnomad AMR exome
AF:
0.0872
Gnomad ASJ exome
AF:
0.256
Gnomad EAS exome
AF:
0.213
Gnomad SAS exome
AF:
0.109
Gnomad FIN exome
AF:
0.183
Gnomad NFE exome
AF:
0.152
Gnomad OTH exome
AF:
0.156
GnomAD4 exome
AF:
0.143
AC:
199879
AN:
1397904
Hom.:
15253
Cov.:
31
AF XY:
0.144
AC XY:
98954
AN XY:
689562
show subpopulations
Gnomad4 AFR exome
AF:
0.0596
Gnomad4 AMR exome
AF:
0.0925
Gnomad4 ASJ exome
AF:
0.263
Gnomad4 EAS exome
AF:
0.195
Gnomad4 SAS exome
AF:
0.114
Gnomad4 FIN exome
AF:
0.180
Gnomad4 NFE exome
AF:
0.142
Gnomad4 OTH exome
AF:
0.154
GnomAD4 genome
AF:
0.132
AC:
20122
AN:
152092
Hom.:
1462
Cov.:
32
AF XY:
0.134
AC XY:
9993
AN XY:
74340
show subpopulations
Gnomad4 AFR
AF:
0.0633
Gnomad4 AMR
AF:
0.133
Gnomad4 ASJ
AF:
0.259
Gnomad4 EAS
AF:
0.198
Gnomad4 SAS
AF:
0.112
Gnomad4 FIN
AF:
0.189
Gnomad4 NFE
AF:
0.155
Gnomad4 OTH
AF:
0.164
Alfa
AF:
0.122
Hom.:
298
Bravo
AF:
0.127
TwinsUK
AF:
0.132
AC:
490
ALSPAC
AF:
0.146
AC:
561
ESP6500AA
AF:
0.0602
AC:
136
ESP6500EA
AF:
0.145
AC:
639
ExAC
AF:
0.0970
AC:
3853

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 22, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 29. Only high quality variants are reported. -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Brugada syndrome 5 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Cardiac arrhythmia Benign:1
Apr 22, 2013
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
11
DANN
Benign
0.93
Eigen
Benign
-0.77
Eigen_PC
Benign
-0.87
FATHMM_MKL
Benign
0.096
N
LIST_S2
Benign
0.41
T;T
MetaRNN
Benign
0.0037
T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.31
T
PROVEAN
Benign
0.010
N;.
REVEL
Benign
0.047
Sift
Pathogenic
0.0
D;.
Polyphen
0.22
B;.
Vest4
0.096
MPC
1.4
ClinPred
0.013
T
GERP RS
1.8
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs67486287; hg19: chr19-35524944; COSMIC: COSV52895059; COSMIC: COSV52895059; API